Xenazine (Lundbeck Pharmaceuticals LLC)


Welcome to the PulseAid listing for the Xenazine drug offered from Lundbeck Pharmaceuticals LLC. This Vesicular Monoamine Transporter 2 Inhibitor [EPC],Vesicular Monoamine Transporter 2 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Lundbeck Pharmaceuticals LLC
NON-PROPRIETARY NAME: tetrabenazine
SUBSTANCE NAME: TETRABENAZINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Vesicular Monoamine Transporter 2 Inhibitor [EPC],Vesicular Monoamine Transporter 2 Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2008-11-24
END MARKETING DATE: 0000-00-00


Xenazine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionXenazine from Lundbeck Pharmaceuticals LLC
LABELER NAME: Lundbeck Pharmaceuticals LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 12.5(mg/1)
START MARKETING DATE: 2008-11-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67386-421_fc606728-65eb-4e1b-a3e2-9c4fb513eddf
PRODUCT NDC: 67386-421
APPLICATION NUMBER: NDA021894

Other TETRABENAZINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AvKARE, Inc.Tetrabenazine
Camber Pharmaceuticals, Inc.Tetrabenazine
Ingenus Pharmaceuticals NJ, LLCTETRABENAZINE
Lundbeck Pharmaceuticals LLCXenazine
Oceanside Pharmaceuticalstetrabenazine
Sun Pharma Global FZETetrabenazine
TAGI Pharma, Inc.Tetrabenazine